Evidence map›Paper›PMID 34414362›Full record

ArticleConditioning medicine2021

Conditioning medicine for ischemic and hemorrhagic stroke.

David C Hess, Mohammad Badruzzaman Khan, Pradip Kamat, Kumar Vaibhav, Krishnan M Dhandapani, Babak Baban, Jennifer L Waller, Md Nasrul Hoda, Rolf Ankerlund Blauenfeldt, Grethe Andersen

Open access · greenAbstract read
In one paragraph

Article in Conditioning medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 6 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

David C HessDepartment of Neurology, Medical College of Georgia, Augusta, GA.
Mohammad Badruzzaman KhanDepartment of Neurology, Medical College of Georgia, Augusta, GA.
Pradip KamatDepartment of Neurology, Medical College of Georgia, Augusta, GA.
Kumar VaibhavDepartment of Neurosurgery, Medical College of Georgia, Augusta, GA.
Krishnan M DhandapaniDepartment of Neurosurgery, Medical College of Georgia, Augusta, GA.
Babak BabanDepartment of Neurology, Medical College of Georgia, Augusta, GA.
Jennifer L WallerPopulation Health Sciences4 Medical College of Georgia, Augusta, GA.
Md Nasrul HodaDepartment of Neurology, Henry Ford Hospital, Detroit, MI.
Rolf Ankerlund BlauenfeldtDepartment of Neurology, Aarhus University Hospital and Clinical Medicine, Aarhus University, Aarhus, Denmark.
Grethe AndersenDepartment of Neurology, Aarhus University Hospital and Clinical Medicine, Aarhus University, Aarhus, Denmark.
Augusta University · USHenry Ford Hospital · US

Funding

Therapeutic Targeting of Monoacylglycerol Lipase After Traumatic Brain InjuryR01NS114560 · NINDS · AUGUSTA UNIVERSITY · PI VAIBHAV, KUMAR · 2020 to 2024
$1.8M
Targeting RBC dysfunction in VCIDRF1NS122863 · NINDS · AUGUSTA UNIVERSITY · PI HESS, DAVID C. · 2021 to 2021
$1.6M
Mechanisms of Chronic Remote Ischemic Conditioning Induced Cerebroprotection in a VCID ModelR01NS099455 · NINDS · AUGUSTA UNIVERSITY · PI HESS, DAVID C. · 2017 to 2020
$1.5M
Neutrophil Activation after Traumatic Brain InjuryR01NS110378 · NINDS · AUGUSTA UNIVERSITY · PI ARBAB, ALI SYED, BABAN, BABAK · 2019 to 2022
$1.5M
Rheoerythrocrine dysfunction in stroke and remote ischemic conditioning (REDS)R01NS112511 · NINDS · AUGUSTA UNIVERSITY · PI HESS, DAVID C. · 2020 to 2023
$1.3M
Remote Ischemic Conditioning: A collateral therapeutic and neuroprotectantU01NS113356 · NINDS · AUGUSTA UNIVERSITY · PI HESS, DAVID C. · 2019 to 2021
$1.1M
Targeting RBC dysfunction in VCIDR01NS122863 · NINDS · AUGUSTA UNIVERSITY · PI HESS, DAVID C. · 2024 to 2025
$1.0M
NINDS NIH HHS R01 NS099455NINDS NIH HHS R01 NS110378NINDS NIH HHS R01 NS112511NINDS NIH HHS R01 NS114560NINDS NIH HHS R01 NS122863NINDS NIH HHS RF1 NS122863NINDS NIH HHS U01 NS113356
6 · The paper itself

Abstract

Remote ischemic conditioning (RIC) is a promising safe, feasible, and inexpensive treatment for acute stroke, both ischemic and hemorrhagic. It is applied with a blood pressure cuff on the limbs and is ideal for the prehospital setting. RIC is a form of preconditioning with similarities to physical exercise. Its mechanisms of action are multiple and include improvement of collateral cerebral blood flow (CBF) and RIC acts as a "collateral therapeutic". The increased CBF is likely related to nitric oxide synthase 3 in the endothelium and more importantly in circulating blood cells like the red blood cell. The RESIST clinical trial is a 1500 subject multicenter, randomized, sham-controlled trial of RIC in the prehospital setting in Denmark and should address the questions of whether RIC is safe and effective in acute stroke and whether the effect is mediated by an effect on nitric oxide/nitrite metabolism.

Indexed as

nitric oxide synthase 3preconditioningred blood cellremote ischemic conditioning

Identifiers

PMID34414362
PMCPMC8372992
OpenAlexW3194901104

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.